ScholarIQanswers from OpenAlex

Combined nanosuspensions from two natural active ingredients for cancer therapy with reduced side effects

PaperCitations, authors & open-access status

Combined nanosuspensions from two natural active ingredients for cancer therapy with reduced side effects is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Combined nanosuspensions from two natural active ingredients for cancer therapy with reduced side effects have?

ScholarIQcitation count

Combined nanosuspensions from two natural active ingredients for cancer therapy with reduced side effects has 26 citations in the OpenAlex counts ScholarIQ stores.

When was Combined nanosuspensions from two natural active ingredients for cancer therapy with reduced side effects published?

ScholarIQyear

Combined nanosuspensions from two natural active ingredients for cancer therapy with reduced side effects has 2021 year in the ScholarIQ index.

What is the open-access status of Combined nanosuspensions from two natural active ingredients for cancer therapy with reduced side effects?

ScholarIQoa status

Combined nanosuspensions from two natural active ingredients for cancer therapy with reduced side effects has closed oa status in the ScholarIQ index.

What is the DOI of Combined nanosuspensions from two natural active ingredients for cancer therapy with reduced side effects?

ScholarIQdoi

The DOI for Combined nanosuspensions from two natural active ingredients for cancer therapy with reduced side effects is on the source record.

What is the OpenAlex record for Combined nanosuspensions from two natural active ingredients for cancer therapy with reduced side effects?

ScholarIQopenalex

The OpenAlex for Combined nanosuspensions from two natural active ingredients for cancer therapy with reduced side effects is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial